The survival rate of PC-3 cells in the CD8+ T cell group was significantly lower than that in CD8+ T cell treated by the PC-3-exos group (p < 0.001), indicating that PCa-exos inhibits the killing activity of CD8+ T cells. This evidence concerns the gene CD8A and posterior cortical atrophy.